Targeting the tumor vascular compartment to improve conventional cancer therapy

Olivier Feron1

  • 1University of Louvain Medical School, Unit of Pharmacology and Therapeutics, UCL-FATH 5349, 53 Avenue E. Mounier, B-1200 Brussels, Belgium. feron@mint.ucl.ac.be

Insights

Tumor vasculature is more complex than previously thought, featuring both mature and immature blood vessels. This heterogeneity influences cancer progression and treatment strategies, requiring dynamic therapeutic approaches.

Area of Science:

  • Oncology
  • Vascular Biology
  • Cancer Therapeutics

Background:

  • Tumor growth relies on a vascular network, historically viewed as immature and non-functional.
  • Targeting tumor vasculature is a developing therapeutic strategy with promising preclinical data.
  • The concept of tumor heterogeneity is now being extended to the tumor vascular compartment.

Purpose of the Study:

  • To challenge the traditional view of uniform tumor vasculature.
  • To highlight the coexistence of mature and immature vessels within tumors.
  • To emphasize the dynamic nature of tumor vascularity in response to time and treatment.

Main Methods:

  • Review of preclinical studies on anti-angiogenic and vascular-targeting drugs.
  • Analysis of recent data on tumor vascular composition.
  • Examination of the temporal and treatment-induced changes in tumor vasculature.

Main Results:

  • Tumor vascular compartments exhibit heterogeneity, comprising both mature and immature vessels.
  • The density and composition of tumor vasculature are dynamic, changing over time.
  • Vascular dynamics are influenced by ongoing treatments.

Conclusions:

  • The concept of tumor heterogeneity must encompass the vascular compartment.
  • Understanding the dynamic coexistence of vessel types is crucial for effective cancer therapy.
  • Future therapeutic strategies should consider the evolving nature of tumor vasculature.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...